Hello everyone. My name is Ahmed Nabil. I'm a medical doctor and a final PhD student, final year PhD student here in London at Imperial College London. I'm a founder I'm the founder of GMT, a company through which we are trying to solve a significant unmet need in minimally invasive surgery. that's frequently overlooked, which is the loss of visual clarity while operating. Today, I'll take you through the very, very unusual journey that I had to go through to build this company. So, I come from Kuwait, a country with no met ecosystem or foundation whatsoever. We're the first met company from Kuwait. And I had the idea to solve the problem of visual um clarity loss in minimally invasive surgery. This is when the surgical camera gets fouled with blood, debris, fatty tissue or condensation and it's a frequent problem that happens in almost every surgery and there was no commercially available solution to the problem. So, I had the idea to create a flushing system around the camera lens, but I didn't know how to build a proof of concept prototype or wait where to go next. So, I applied to a TV show similar to Shark Tank uh that's called Stars of Science. It's similar to Dragon's Den in the UK. So, you see me here pitching to a a panel of judges who are investors, surgeons, and professors. But to make my life more challenging, they decided to bring one of the top surgeons in the world who is a former health minister here in the UK and was kned by Queen Elizabeth for his contributions to the field of minimally invasive surgery. Lord Aradzi amongst other clinicians from Mayo Clinic and Cleveland Clinic and other Everyone, all my colleagues thought I was ridiculous and crazy for doing this. So the problem is the loss of visual acuity or clarity in minimally invasive surgery by blood fog or um body fluids. And the way to restore clarity is to pose the procedure, take the camera out and clean it manually, which is disruptive to the surgical flow and raises significant patient safety So studies show that it can this problem can consume about 50% of operative time may add up to 15 minutes per case and one in every five surgical errors is contributed to poor visualization. Approximately 75% of lawsuits against surgeons are due to intraoperative surgical errors and roughly $6 billion in medical error cost in the US alone annually is uh due to surgical errors. So the surgeon's ability to see clearly is the foundation upon which every successful operation is built. So was I the only surgeon to spot this problem? No. This is a study that we published in one of the top two surgical journals globally. 94% of surgeons agree that this is a major problem in minimally invasive surgery. Two independent research groups also published and verified our uh findings. Uh one in Germany and the other one in South Korea. um they were trying to assess business opportunities for future robotic and AI platforms and a requirement for uh self-cleaning camera was amongst the top uh two required features in both Over 61% of surgeons reported witnessing direct surgical complications that were attributed to loss of visual clarity. And we assessed we evaluated the cost the cost analysis of uh the uh vision related delays in minimally invasive surgery and for one type of procedure only which is the sleeve gasterectomy it was $25 million in the US across all specialtities and procedures that's roughly 2.2 billion in the US alone. This is another study that we published. The solution we call it cleanse. It's a system or a platform that consists of a capital equipment which you see here. This is the brain of the system and there is a disposable component that you can attach to existing surgical cameras. Um we combine multi-cleaning modalities in a single embodiment. Uh it's a prop proprietary uh technology. We have multiple issued patents in different countries and regions. So here you can see some of the benchtop testing that we did. In the first row you see images of a perfect image before we applied any challenge conditions. And then we used different contaminants that we um ensured would be more difficult and stubborn to clean than things you would encounter normally in a routine procedure. We used mayo to resemble fat. We also used pork belly fat and we used ketchup to resemble blood which has higher viscosity and density than blood. 27 times higher. In the bottom row you can see the visual clarity after one cleaning cycle with our solution. Sometimes it doesn't reach the 100% clarity and you just press the button twice and then you will get it. We never had an instance in our benchtop testing where we needed to do more than two cleaning cycles. This is a video that um I would like to share with you where Dr. Michael Kendrick, the chief of surgery at Mayo Clinic, is demonstrating uh our technology. On the left, there is a surgical surgical camera with our system attached to it. And on the right, the conventional way to clean the Both cameras are compromised. On the left, you see in less than one second, you restore the visual clarity. On the right, Dr. Kendrick still trying to get a clear image. The second he inserts the camera again through the port, it is fouled again by blood because the port itself is not clean. This is the second time. Now, he rubs the camera on the liver to gain a clear image, which is clinically not advisable according to many published research. This is our team. My co-founder is Dr. Salman Subah. He's a consultant pediatric surgeon trained in Canada and uh America. He's a Harvard graduate with over 200 uh peer-reviewed publications with our general cancer and CTO. We have an outstanding advisory board compromising the chief of surgery at Mayo Clinic, Dr. Kendrick Tar Sultan who built multiple multi-billion dollar businesses and uh Dr. Phil Shawer uh who is considered one of the main pioneers of buriatric procedures globally. These are some of the milestones that we were able to achieve. Um we secured a deal with Mayo Clinic where we are currently co-developing the technology with them. We've been featured with Ted Datson on his TV show called Advancements on Bloomberg TV. And we've been named Health Tech Company of the Year by Entrepreneur Magazine. The total addressable market is basically any procedure that uses a surgical camera. This is a 200 to 250 million um procedures annually according to publicly available estimates. Our business model is mainly uh recurring revenue from the disposable component which we aim to sell for $150. Um and the total opportunity size is more than $10 billion globally. We also have in the pipelines an AI powered computer vision system that we're working on that can enhance the picture digitally to remove for example smoke or also to make the entire process of restoring visual clarity completely autonomous that does not require any human input. We have a very robust IP portfolio. four granted patents, two in the US, one in Japan, one in Saudi Arabia, 15 uh filings pending and um new provisional patents to be filed very soon. Our regulatory strategy is a 510K for FDA clearance. We can use that clearance also to commercialize in the Gulf region in the Middle East. So, back to the TV show. Not only did I end up winning the season I was on, but also I am now a recurring uh judge on the same TV show for the fourth year. Now, Lord Darzi, the uh supposedly one time interaction that I had with him has now turned into um he was my uh master's supervisor and currently my PhD supervisor for the sixth year now. These are some of the awards that we won. uh most notably the MIT Tech Review Award which has been previously given to the founders of Google, Facebook, Tesla and Twitter. We went from a country with no MT tech whatsoever to signing a partnership with the leading healthcare institution in the world. Um now also in Kuwait, all schools feature GMT stories in the official curriculum across all schools in Kuwait. We're currently raising our series A uh looking to raise $8 million. We have about 90% of that already committed. So, we may have one to maximum $2 million available for investment. If you're interested, please let me know and reach out. We're on a mission to hopefully set a new global standard that would enhance patient safety and contribute to saving lives directly. Thank you so much.